Director, Program Management, Oncology

Corcept is engaged in the discovery and development of drugs that treat severe endocrine, metabolic, oncologic and neurological disorders by modulating the effects of the hormone cortisol. Since 2012, we have marketed Korlym^® for the treatment of patients suffering from Cushing’s syndrome, life-threatening orphan disorder caused by excess cortisol activity.

In addition to our commercial product, Korlym, we have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators.  Lead compounds are in Phase 2 and Phase 3 trials for the treatment of patients with Cushing’s syndrome, advanced ovarian cancer, castration-resistant prostate cancer, weight gain caused by antipsychotic medications and non-alcoholic steatohepatitis (“NASH”).  We are about to start a Phase 2 trial in patients with amyotrophic lateral sclerosis (“ALS”).

In 2020, we generated revenue of $366 million and net income of $112 million.

Director Program Management, Oncology

 Corcept is committed to improving patient lives through the discovery and development of drugs that address serious unmet medical needs related to excess cortisol activity.

Cortisol dysregulation plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric, and ophthalmologic diseases. Corcept leads the field in the research and development of selective glucocorticoid receptor (GR) antagonists, having discovered more than 500 proprietary molecules since its founding in 1998.

Director, Program Management – Oncology:

The Program Director will lead one or more cross-functional drug development program teams including research, development, and commercial representatives.

Responsibilities:

• Lead and coordinate all cross-functional activities related to clinical development, CMC, and regulatory for a new therapeutic
• Develop integrated development plans and drive execution. Anticipate issues and proactively mitigate risks and roadblocks.  Direct program team to achieve targets within appropriate quality standards, deadlines, budget, and resources
• Drive program level decision-making
• Ensure appropriate and effective communication within the program team, senior management, and the executive team, including the CEO
• Represent development point of view in commercial planning and decision making
• Provide formal and informal reports of program status to stakeholders

Preferred Skills, Qualifications and Technical Proficiencies:

• Demonstrated program leadership skills and ability to manage, motivate, and integrate complex, cross-functional drug development teams
• Analytical skills and ability to focus on both details and the big picture
• Excellent interpersonal, problem solving, and influence/negotiation skills
• Knowledge of regulatory guidelines for drug development functions (ICH and FDA)
• Able to navigate uncertainty with creative problem solving
• Ability to achieve business results with colleagues of diverse levels, functional expertise, skills, and priorities. Effective as both a team player and a team leader
• Ability to take a hands-on, “roll up your sleeves” approach

Preferred Education and Experience:

• Master’s Degree in a life science or related field or equivalent experience
• At least 10 years project management experience in drug development in the pharmaceutical industry, including Phases 1-3, regulatory filings and product launch
• PMP or other Project Management Institute certification

Applicants must be currently authorized to work in the United States on a full-time basis.

If you are based in California, we encourage you to read this important information for California residents linked here.

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

 Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer